Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.98 USD | +4.86% | +6.36% | -28.31% |
01:15am | Transcript : Immunocore Holdings plc - Shareholder/Analyst Call | |
May. 29 | Immunocore Converts Skin Cancer Therapy Phase 2/3 Trial to Phase 3 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.31% | 2.34B | |
+40.73% | 734B | |
+32.83% | 591B | |
-6.30% | 350B | |
+15.15% | 315B | |
+4.05% | 276B | |
+15.00% | 238B | |
+9.78% | 206B | |
-5.52% | 204B | |
+6.17% | 161B |
- Stock Market
- Equities
- IMCR Stock
- News Immunocore Holdings plc
- Transcript : Immunocore Holdings plc Presents at Bank of America Securities 2023 Healthcare Conference, May-10-2023 05